Free tool
Healthcare stocks
We cover 107 companies in the Healthcare sector. The median market value in the group is $1.63B. Across the group, the median move over the past trading day is +0.31%. 98% of the 105 with a 200-day average trade above it. Price change over the past year runs from −19.8% to +282.6% across the middle 80 percent of the group, with a median of +51.4%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
107 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% | Oct 29, 2026 |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% | Nov 3, 2026 |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% | Oct 21, 2026 |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | 717.90 EUR | +25.00% | +8.96% | −5.91% | Oct 28, 2026 |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% | Oct 22, 2026 |
| 0QF.DE | Moderna, Inc. | 136.12 EUR | +181.04% | +417.17% | +550.51% | Nov 5, 2026 |
| BOX.DE | Becton, Dickinson and Company | 168.80 EUR | +23.08% | +2.38% | +1.73% | Nov 5, 2026 |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% | Nov 5, 2026 |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% | Nov 5, 2026 |
| IQV | IQVIA Holdings Inc. | $261.51 | +7.64% | +16.04% | +38.51% | Nov 3, 2026 |
| ILU.DE | Illumina, Inc. | 193.08 EUR | +13.91% | +69.73% | +129.80% | Oct 29, 2026 |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% | Oct 29, 2026 |
| 22UA.DE | BioNTech SE | 100.00 EUR | +23.08% | +21.29% | +14.09% | Nov 3, 2026 |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% | Nov 3, 2026 |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% | Oct 20, 2026 |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% | Nov 5, 2026 |
| GE9.DE | Genmab A/S | 294.20 EUR | +17.26% | +9.78% | −11.12% | Nov 5, 2026 |
| CRL | Charles River Laboratories International, Inc. | $295.10 | +22.74% | +45.79% | +81.27% | Nov 4, 2026 |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% | Nov 2, 2026 |
| BIO | Bio-Rad Laboratories, Inc. | $388.64 | +17.41% | +27.31% | +32.71% | Oct 29, 2026 |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% | Nov 3, 2026 |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% | Nov 9, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% | Nov 5, 2026 |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% | Nov 5, 2026 |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% | Nov 4, 2026 |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% | Nov 11, 2026 |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% | Nov 5, 2026 |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% | Nov 11, 2026 |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% | Oct 29, 2026 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.08 | +89.67% | +224.69% | +292.38% | Nov 5, 2026 |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% | Nov 9, 2026 |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% | Nov 5, 2026 |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% | Nov 9, 2026 |
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% | Nov 5, 2026 |
| MRVI | Maravai LifeSciences Holdings, Inc. | $8.90 | +29.74% | +161.76% | +281.97% | Nov 5, 2026 |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% | Nov 5, 2026 |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% | Nov 12, 2026 |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% | Nov 3, 2026 |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% | Nov 13, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% | Nov 5, 2026 |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% | Nov 13, 2026 |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% | Oct 27, 2026 |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% | Nov 4, 2026 |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% | Nov 5, 2026 |
| PRGO | Perrigo Company plc | $14.76 | +43.30% | +8.65% | −36.05% | Nov 4, 2026 |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% | Nov 4, 2026 |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% | Nov 5, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% | Nov 13, 2026 |
| ETON | Eton Pharmaceuticals, Inc. | $62.62 | +34.20% | +285.12% | +262.38% | Nov 12, 2026 |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% | Nov 9, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% | Nov 5, 2026 |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% | Nov 4, 2026 |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% | Nov 11, 2026 |
| OMER | Omeros Corporation | $18.22 | +61.52% | +11.23% | +328.71% | Nov 12, 2026 |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% | Sep 10, 2026 |
| CRON.TO | Cronos Group Inc. | 4.95 CAD | +23.75% | +34.15% | +39.83% | Nov 5, 2026 |
| CRON | Cronos Group Inc. | $3.55 | +24.56% | +31.48% | +38.67% | Nov 5, 2026 |
| 6523.T | PHC Holdings Corporation | 1,527.00 JPY | +36.71% | +37.93% | +58.42% | Nov 11, 2026 |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% | Nov 5, 2026 |
| HELP | Cybin D/B/A Helus Pharma | $13.63 | +79.34% | +64.61% | +77.71% | Nov 12, 2026 |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% | Nov 5, 2026 |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% | Nov 17, 2026 |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% | Nov 3, 2026 |
| OABI | OmniAb, Inc. | $4.81 | +144.16% | +155.85% | +198.76% | Nov 4, 2026 |
| AQST | Aquestive Therapeutics, Inc. | $5.39 | +43.35% | −16.43% | +40.00% | Nov 4, 2026 |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% | Nov 12, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% | Nov 11, 2026 |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% | Oct 23, 2026 |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% | Sep 8, 2026 |
| SENS | Senseonics Holdings, Inc. | $9.34 | +90.22% | +58.57% | +0.43% | Nov 4, 2026 |
| SGHT | Sight Sciences, Inc. | $8.37 | +57.92% | +11.90% | +97.87% | Nov 5, 2026 |
| ARCT | Arcturus Therapeutics Holdings Inc. | $15.83 | +175.30% | +153.28% | −8.44% | Nov 9, 2026 |
| CARL | Carlsmed, Inc. | $16.18 | +31.44% | +39.12% | +16.40% | Nov 5, 2026 |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% | Nov 6, 2026 |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% | Aug 31, 2026 |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% | Oct 22, 2026 |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% | Nov 5, 2026 |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% | Nov 11, 2026 |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% | Nov 3, 2026 |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% | Nov 12, 2026 |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% | Aug 28, 2026 |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% | Sep 29, 2026 |
| ACB | Aurora Cannabis Inc. | $4.00 | +47.06% | −7.83% | −24.95% | Nov 4, 2026 |
| ACB.TO | Aurora Cannabis Inc. | 5.54 CAD | +44.65% | −6.73% | −24.93% | Nov 4, 2026 |
| CRDL | Cardiol Therapeutics Inc. | $2.14 | +78.33% | +115.29% | +91.07% | Nov 12, 2026 |
| CRDL.TO | Cardiol Therapeutics Inc. | 2.97 CAD | +74.71% | +118.38% | +90.38% | Nov 12, 2026 |
| XLY.TO | Auxly Cannabis Group Inc. | 3.13 CAD | +19.92% | +2058.62% | +1919.35% | Nov 12, 2026 |
| NGEN | NervGen Pharma Corp. | $2.21 | +37.27% | −62.41% | −8.30% | Nov 23, 2026 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% | Nov 16, 2026 |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% | Nov 12, 2026 |
| XGN | Exagen Inc. | $7.67 | +72.36% | +26.99% | −19.69% | Nov 10, 2026 |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% | Nov 11, 2026 |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% | Nov 3, 2026 |
| BMEA | Biomea Fusion, Inc. | $1.71 | +36.80% | +27.61% | −8.06% | Nov 3, 2026 |
| LUNG | Pulmonx Corporation | $2.50 | +100.00% | +8.70% | +34.41% | Nov 11, 2026 |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% | Oct 29, 2026 |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% | Oct 30, 2026 |
| HBIO | Harvard Bioscience, Inc. | $7.65 | +29.22% | +17.69% | +44.34% | Nov 5, 2026 |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% | Nov 9, 2026 |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% | Nov 11, 2026 |
| LUCY | Lucyd, Inc | $1.13 | +52.50% | −0.88% | −42.05% | Nov 12, 2026 |
| SKYE | Skye Bioscience, Inc. | $2.02 | +228.46% | +130.07% | −41.62% | Nov 9, 2026 |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% | Oct 23, 2026 |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.